Protagonist Therapeutics appoints Suneel Gupta as EVP, Clinical Development

Protagonist Therapeutics, Inc

Effective Jan 1, 2025, Suneel Gupta transitioned from Chief Development Officer to EVP, Clinical Development.
Gupta, previously CDO, now serves as Executive Vice President, Clinical Development.
No other officer changes were reported in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Suneel Gupta

Executive Vice President, Clinical Development

PTGX · Protagonist Therapeutics, Inc

Effective: 2025-01-01
Filed: January 6, 2025, 6:59 PM ET

Effective January 1, 2025, Suneel Gupta, Ph.D., Protagonist Therapeutics, Inc.’s Chief Development Officer, transitioned to Executive Vice President, Clinical Development.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Suneel Gupta changed role as Executive Vice President, Clinical Development at Protagonist Therapeutics, Inc.

Action: transitioned
Role: Executive Vice President, Clinical Development

Exact text from the filing

Effective January 1, 2025, Suneel Gupta, Ph.D., Protagonist Therapeutics, Inc.’s Chief Development Officer, transitioned to Executive Vice President, Clinical Development.

View on SEC.gov

Protagonist Therapeutics, Inc filing history →

Source: SEC EDGAR

accession 0001104659-25-001304

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.